OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
HER2-Specific Reduction-Sensitive Immunopolymersomes with High Loading of Epirubicin for Targeted Treatment of Ovarian Tumor
Lin Ding, Wenxing Gu, Yifan Zhang, et al.
Biomacromolecules (2019) Vol. 20, Iss. 10, pp. 3855-3863
Open Access | Times Cited: 16
Lin Ding, Wenxing Gu, Yifan Zhang, et al.
Biomacromolecules (2019) Vol. 20, Iss. 10, pp. 3855-3863
Open Access | Times Cited: 16
Showing 16 citing articles:
Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
Wenxing Gu, Fenghua Meng, Rainer Haag, et al.
Journal of Controlled Release (2020) Vol. 329, pp. 676-695
Closed Access | Times Cited: 146
Wenxing Gu, Fenghua Meng, Rainer Haag, et al.
Journal of Controlled Release (2020) Vol. 329, pp. 676-695
Closed Access | Times Cited: 146
Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo
Yaohua Wei, Xiaolei Gu, Yinping Sun, et al.
Journal of Controlled Release (2020) Vol. 319, pp. 407-415
Open Access | Times Cited: 89
Yaohua Wei, Xiaolei Gu, Yinping Sun, et al.
Journal of Controlled Release (2020) Vol. 319, pp. 407-415
Open Access | Times Cited: 89
Polymersome-based protein drug delivery – quo vadis?
Micael G. Gouveia, Justus Paul Wesseler, Jobbe Ramaekers, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 2, pp. 728-778
Open Access | Times Cited: 61
Micael G. Gouveia, Justus Paul Wesseler, Jobbe Ramaekers, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 2, pp. 728-778
Open Access | Times Cited: 61
Emerging targeted drug delivery strategies toward ovarian cancer
Zhe Wang, Fenghua Meng, Zhiyuan Zhong
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113969-113969
Closed Access | Times Cited: 51
Zhe Wang, Fenghua Meng, Zhiyuan Zhong
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113969-113969
Closed Access | Times Cited: 51
Small, Smart, and LDLR-Specific Micelles Augment Sorafenib Therapy of Glioblastoma
Jingjing Wei, Yifeng Xia, Fenghua Meng, et al.
Biomacromolecules (2021) Vol. 22, Iss. 11, pp. 4814-4822
Closed Access | Times Cited: 19
Jingjing Wei, Yifeng Xia, Fenghua Meng, et al.
Biomacromolecules (2021) Vol. 22, Iss. 11, pp. 4814-4822
Closed Access | Times Cited: 19
Cetuximab–Polymersome–Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers
Shujing Yue, Yifan Zhang, Yaohua Wei, et al.
Biomacromolecules (2021) Vol. 23, Iss. 1, pp. 100-111
Closed Access | Times Cited: 18
Shujing Yue, Yifan Zhang, Yaohua Wei, et al.
Biomacromolecules (2021) Vol. 23, Iss. 1, pp. 100-111
Closed Access | Times Cited: 18
Development of HER2-Targeting-Ligand-Modified Albumin Nanoparticles Based on the SpyTag/SpyCatcher System for Photothermal Therapy
Changkyu Lee, Sebyung Kang
Biomacromolecules (2021) Vol. 22, Iss. 6, pp. 2649-2658
Closed Access | Times Cited: 17
Changkyu Lee, Sebyung Kang
Biomacromolecules (2021) Vol. 22, Iss. 6, pp. 2649-2658
Closed Access | Times Cited: 17
Polymersome-stabilized doxorubicin-lipiodol emulsions for high-efficacy chemoembolization therapy
Jingyi Liu, Lei Zhang, Dongxu Zhao, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 122-131
Closed Access | Times Cited: 11
Jingyi Liu, Lei Zhang, Dongxu Zhao, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 122-131
Closed Access | Times Cited: 11
Nanobodies Enhancing Cancer Visualization, Diagnosis and Therapeutics
Dhaneshree Bestinee Naidoo, Anil A. Chuturgoon
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9778-9778
Open Access | Times Cited: 14
Dhaneshree Bestinee Naidoo, Anil A. Chuturgoon
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9778-9778
Open Access | Times Cited: 14
HER-2-mediated nano-delivery of molecular targeted drug potently suppresses orthotopic epithelial ovarian cancer and metastasis
Zhe Wang, Beibei Guo, Shujing Yue, et al.
International Journal of Pharmaceutics (2022) Vol. 625, pp. 122126-122126
Closed Access | Times Cited: 10
Zhe Wang, Beibei Guo, Shujing Yue, et al.
International Journal of Pharmaceutics (2022) Vol. 625, pp. 122126-122126
Closed Access | Times Cited: 10
Antibacterial metal-phenolic nanosheets as smart carriers for the controlled release of epirubicin hydrochloride
Wei Ha, Jun‐Li Yang, Yan‐Ping Shi
Nanoscale (2022) Vol. 14, Iss. 27, pp. 9806-9817
Closed Access | Times Cited: 9
Wei Ha, Jun‐Li Yang, Yan‐Ping Shi
Nanoscale (2022) Vol. 14, Iss. 27, pp. 9806-9817
Closed Access | Times Cited: 9
The rise of bio-inspired polymer compartments responding to pathology-related signals
Luisa Zartner, Moritz S. Muthwill, Ionel Adrian Dinu, et al.
Journal of Materials Chemistry B (2020) Vol. 8, Iss. 29, pp. 6252-6270
Open Access | Times Cited: 13
Luisa Zartner, Moritz S. Muthwill, Ionel Adrian Dinu, et al.
Journal of Materials Chemistry B (2020) Vol. 8, Iss. 29, pp. 6252-6270
Open Access | Times Cited: 13
CD38-selective immuno-nano-DM1 conjugates for depleting multiple myeloma
Yuan Qin, Daoyang Fan, Yifan Zhang, et al.
Biomaterials Science (2023) Vol. 11, Iss. 14, pp. 4985-4994
Closed Access | Times Cited: 2
Yuan Qin, Daoyang Fan, Yifan Zhang, et al.
Biomaterials Science (2023) Vol. 11, Iss. 14, pp. 4985-4994
Closed Access | Times Cited: 2
Bioresponsive Polymeric Nanoparticles: From Design, Targeted Therapy to Cancer Immunotherapy
Huanli Sun, Zhiyuan Zhong
Biomacromolecules (2024) Vol. 26, Iss. 1, pp. 33-42
Closed Access
Huanli Sun, Zhiyuan Zhong
Biomacromolecules (2024) Vol. 26, Iss. 1, pp. 33-42
Closed Access
